Barbara Handelin

Barbara Handelin, PhD has extensive work experience in the biotech and healthcare industries. Barbara is currently the CEO and Founder of The 90 / 10 Institute, a nonprofit company that aims to address the gaps in the biotech industry by producing affordable and effective medicines for a wider range of human maladies. Prior to this, they founded NovoKen, where they focused on accelerating the discovery of cures for rare diseases. Barbara also has experience as a Consultant at Handelin Associates, where they provided services to venture capital investors and various biotech companies. Barbara served as the CEO of Audacity Therapeutics, PBC, a drug development company dedicated to creating affordable drugs for more diseases. Barbara is a CoFounder of BioPontis Alliance for Rare Diseases, an international philanthropic organization that focuses on drug discovery and development for rare diseases. Barbara also served as the President of BioPontis Alliance, LLC, a research and development company focused on sourcing innovative therapeutic products. Other roles they held include being a member of Springboard Enterprises, serving on the Board of Directors of RedPath Integrated Pathology, and being the CEO of Kenna Technologies, a biosimulation start-up. Barbara's early career included serving as the Director of the DNA Diagnostics Lab at Integrated Genetics, where they led the establishment of the largest commercial DNA testing lab in the world. Overall, Barbara Handelin, PhD has dedicated their career to driving innovation and finding solutions in the biotech and healthcare fields.

Barbara Handelin, PhD has a Bachelor's degree in Genetics from the University of California, Berkeley, which they obtained between 1974 and 1978. Barbara continued their education at Oregon Health & Science University, where they completed their PhD in Human Molecular Genetics from 1980 to 1987. Additionally, they pursued thesis work in Biology/Genetics at the Massachusetts Institute of Technology from 1984 to 1987. Barbara Handelin also holds a Certificate of Non-Profit Management from the University of Delaware Biden School of Business and Public Policy, although the specific dates of completion are not provided.